BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 36121473)

  • 1. [Diagnostics in unclear cytopenia-How and when do we screen for clonal hematopoiesis?].
    Haferlach C; Heuser M
    Inn Med (Heidelb); 2022 Nov; 63(11):1141-1147. PubMed ID: 36121473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Challenge and Clinical Dilemma: The Long Reach of Clonal Hematopoiesis.
    Osman A; Patel JL
    Clin Chem; 2021 Aug; 67(8):1062-1070. PubMed ID: 34263288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How I investigate Clonal cytogenetic abnormalities of undetermined significance.
    Tang G; Medeiros LJ; Wang SA
    Int J Lab Hematol; 2018 Aug; 40(4):385-391. PubMed ID: 29624895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ICUS/CCUS/CHIP: basics & beyond.
    Jain M; Tripathi A
    Expert Rev Hematol; 2017 Oct; 10(10):915-920. PubMed ID: 28832236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clonal hematopoiesis of undetermined potential (CHIP) and clonal cytopenia of unknown significance (CCUS) - Consequences for the clinic].
    Ziemann F; Metzeler KH
    Dtsch Med Wochenschr; 2023 Apr; 148(8):441-450. PubMed ID: 36990116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The shadowlands of MDS: idiopathic cytopenias of undetermined significance (ICUS) and clonal hematopoiesis of indeterminate potential (CHIP).
    Malcovati L; Cazzola M
    Hematology Am Soc Hematol Educ Program; 2015; 2015():299-307. PubMed ID: 26637737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal Hematopoiesis of Indeterminate Potential.
    Heuser M; Thol F; Ganser A
    Dtsch Arztebl Int; 2016 May; 113(18):317-22. PubMed ID: 27215596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Premalignant Clonal Hematopoiesis (Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenia of Undetermined Significance).
    Craven KE; Ewalt MD
    Clin Lab Med; 2023 Dec; 43(4):565-576. PubMed ID: 37865503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of clonal hematopoiesis, subtypes and its role in neoplasia and different morbidities.
    Younes IE; Syler L; Hamed A
    Leuk Res; 2023 Jul; 130():107307. PubMed ID: 37186988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications and genetic features of clonal cytopenia of undetermined significance compared to lower-risk myelodysplastic syndrome.
    Choi EJ; Cho YU; Hur EH; Park HS; Choi Y; Lee JH; Lee KH; Kim M; Hwang SH; Jang S; Park CJ; Seo EJ; Lee JH
    Br J Haematol; 2022 Aug; 198(4):703-712. PubMed ID: 35612271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal Hematopoiesis: Origins and determinants of evolution.
    Mendez LM; Patnaik MM
    Leuk Res; 2023 Jun; 129():107076. PubMed ID: 37075557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum From Clonal Hematopoiesis to Myelodysplastic Neoplasm/Syndromes and Other Myeloid Neoplasms.
    Xie Z; Chen EC; Mendez LM; Komrokji R; Zeidan AM
    Cancer J; 2023 May-Jun 01; 29(3):130-137. PubMed ID: 37195768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From clonal hematopoiesis to myeloid leukemia and what happens in between: Will improved understanding lead to new therapeutic and preventive opportunities?
    Bewersdorf JP; Ardasheva A; Podoltsev NA; Singh A; Biancon G; Halene S; Zeidan AM
    Blood Rev; 2019 Sep; 37():100587. PubMed ID: 31400824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Aspects of Clonal Hematopoiesis: Implications for Clinical Diagnosis.
    Karner K; George TI; Patel JL
    Ann Lab Med; 2019 Nov; 39(6):509-514. PubMed ID: 31240877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.
    Steensma DP; Bejar R; Jaiswal S; Lindsley RC; Sekeres MA; Hasserjian RP; Ebert BL
    Blood; 2015 Jul; 126(1):9-16. PubMed ID: 25931582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHIP, CCUS, and Other Acronyms: Definition, Implications, and Impact on Practice.
    DeZern AE; Malcovati L; Ebert BL
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():400-410. PubMed ID: 31099654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolutionary landscape of clonal hematopoiesis in 3,359 individuals from the general population.
    van Zeventer IA; de Graaf AO; Salzbrunn JB; Nolte IM; Kamphuis P; Dinmohamed A; van der Reijden BA; Schuringa JJ; Jansen JH; Huls G
    Cancer Cell; 2023 Jun; 41(6):1017-1031.e4. PubMed ID: 37146604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic and prognostic role of flow cytometry in idiopathic and clonal cytopenia of undetermined significance (ICUS/CCUS): A single-center analysis of 79 patients.
    Dimopoulos K; Hansen OK; Sjö LD; Saft L; Schjødt IM; Werner Hansen J; Grønbaek K
    Cytometry B Clin Cytom; 2020 May; 98(3):250-258. PubMed ID: 31479199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and pathological features of clonal cytopenia of undetermined significance presenting with isolated thrombocytopenia (CCUS-IT).
    O'Neill C; Nwachukwu N; Vergara-Lluri M; Hagiya A; O'Connell CL
    Eur J Haematol; 2024 Apr; 112(4):594-600. PubMed ID: 38088145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ICUS, IDUS, CHIP and CCUS: Diagnostic Criteria, Separation from MDS and Clinical Implications.
    Valent P
    Pathobiology; 2019; 86(1):30-38. PubMed ID: 29860246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.